0.00Open0.30Pre Close0 Volume88 Open Interest7.50Strike Price0.00Turnover643.47%IV314.89%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.3306Delta0.1509Gamma6.27Leverage Ratio-0.0301Theta0.0001Rho2.07Eff Leverage0.0014Vega
LAVA Therapeutics Stock Discussion
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet